{"id":"ab-106-digoxin","safety":{"commonSideEffects":[{"rate":"10%","effect":"Nausea"},{"rate":"5%","effect":"Vomiting"},{"rate":"2%","effect":"Arrhythmia"},{"rate":"1%","effect":"Dysrhythmia"},{"rate":"1%","effect":"Bradycardia"},{"rate":"1%","effect":"Hypotension"},{"rate":"5%","effect":"Fatigue"},{"rate":"5%","effect":"Headache"},{"rate":"2%","effect":"Dizziness"},{"rate":"1%","effect":"Confusion"}]},"_chembl":{"chemblId":"CHEMBL1751","moleculeType":"Small molecule","molecularWeight":"780.95"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Digoxin works by inhibiting the sodium-potassium ATPase pump, which leads to an increase in intracellular sodium and a decrease in intracellular potassium. This increase in intracellular sodium and decrease in intracellular potassium increases the force of cardiac contractions and slows the heart rate.","oneSentence":"Digoxin inhibits the sodium-potassium ATPase pump.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T04:51:26.750Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Atrial fibrillation"},{"name":"Heart failure"}]},"trialDetails":[{"nctId":"NCT05357911","phase":"PHASE1","title":"A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin","status":"COMPLETED","sponsor":"Nuvation Bio Inc.","startDate":"2021-07-13","conditions":"Solid Tumor","enrollment":16}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"AB-106, digoxin","genericName":"AB-106, digoxin","companyName":"Nuvation Bio Inc.","companyId":"nuvation-bio-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Digoxin inhibits the sodium-potassium ATPase pump. Used for Atrial fibrillation, Heart failure.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}